Ordering Recommendation: Testing should only be performed on individuals meeting Centers for Disease Control and Prevention (CDC) clinical criteria for Zika virus (eg, clinical signs and symptoms associated with Zika virus infection) and/or CDC epidemiological criteria for Zika virus (eg, history of residence in or travel to a geographic region with active Zika transmission at the time of travel, or other epidemiological criteria for which Zika virus testing may be indicated).
It is recommended to test both blood and urine sample types.
Qualitative Polymerase Chain Reaction
Reference Interval: | Not Detected |
A positive RT-PCR result confirms Zika virus infection, and no additional testing is indicated. When test results are negative, the serum should be tested as outlined in the current CDC-issued algorithm.
The Zika Virus by PCR test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA). This test has not been FDA cleared or approved. In compliance with this authorization, please visit Zika Virus Test Information for more information and to access the applicable information sheets.
6 mL blood in GOLD SST or RED TOP tube
Outside Laboratories: Centrifuge sample and transfer serum to a separate plastic vial. Freeze serum at -20°C while awaiting shipment. Transport on dry ice.
Stability: Frozen (preferred): 6 weeks; Refrigerated: 5 days; Ambient: Unacceptable.
Centrifuge sample and transfer serum to a separate plastic vial. Freeze serum at -20°C.
Sendouts:
Stability: Frozen (preferred): 6 weeks; Refrigerated: 5 days; Ambient: Unacceptable.
Sendout |
ARUP Laboratories, Inc.
800-522-2787 500 Chipeta Way |
---|
CPT: 87662